MedPath

A Randomised Controlled Trial Comparing Topical Glycerol versus Narrow Band Ultraviolet Light B in Atopic Dermatitis: A Clinical and Bacteriological Evaluatio

Not Applicable
Conditions
Skin and Connective Tissue Diseases
Registration Number
PACTR201810815694251
Lead Sponsor
Cairo University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Patients with mild to moderate atopic dermatitis, defined according to Hanifin and Rajka criteria by the presence of 3 major and 3 minor criteria, and by scoring less than 50 points in SCORAD.
Both genders.
Age more than 6 years old, as children less than 6 are not allowed to be treated by whole cabinet NB-UVB as per phototherapy unit regulations.

Exclusion Criteria

Severe AD: SCORAD>50 (Oranje, 2011).
Erythrodermic patients and those indicated for more aggressive systemic immune suppressive therapy.
Patients receiving systemic treatment within one month or topical treatment within 2 weeks before enrollment into the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath